iNtRON confirms cancer-controlling effect of PHAGERIA® drug candidate in the organoid model. ...Middle East

PR Newswire - Economy
Secured the effectiveness confirming data of PHAGERIA® technology for colorectal cancer organoids The first target cancer type of PHAGERIA® technology is colorectal cancer (CRC) BOSTON and SEOUL, South Korea, April 3, 2023 /PRNewswire/ -- iNtRON Biotechnology ("iNtRON",...

Read More Details
Finally We wish PressBee provided you with enough information of ( iNtRON confirms cancer-controlling effect of PHAGERIA® drug candidate in the organoid model. )

Apple Storegoogle play

Also on site :



Latest News